213
About 300,000 adults and children suffer from severe asthma in Italy. For them now comes the news of the European approval of a new drug to be used as an additional maintenance therapy in patients from the age of 12. Approval in the European Union follows the recommendation of the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) of July 2022.